Can changing estrogen exposure during perimenopause contribute to mood changes and bloating?

Perimenopause involves substantial within-person estradiol variability—not simply a linear decline—providing a credible biological context for both mood symptoms and perceived fluid retention.

Mood and neurotransmitter effects

• Estradiol modulates serotonin synthesis and receptor signaling, including 5-HT1A pathways, and influences dopamine and norepinephrine systems. These networks participate in emotional regulation, reward, anxiety, irritability, and stress responsiveness.
• Progesterone-related variation may also matter: changes in allopregnanolone and GABA-A signaling can alter inhibitory tone and stress sensitivity. Mood symptoms therefore should not be viewed as an estrogen-only phenomenon.
• Clinical data support increased vulnerability during the transition, but not a universal direct hormone–symptom relationship. In the large longitudinal SWAN cohort, perimenopause independently predicted elevated depressive symptoms, whereas estradiol level, annual change, and measured variability did not independently predict symptoms. Smaller longitudinal studies have linked greater estradiol variability with depressive symptoms, anger/irritability, and rejection sensitivity, especially after substantial stress exposure.

Fluid regulation and bloating

• Estradiol can alter renal sodium handling, plasma volume, thirst, and the osmotic threshold for arginine-vasopressin release; lower thresholds favor water conservation. It can also influence the renin–angiotensin–aldosterone system, affecting downstream sodium and water retention.
• These mechanisms make transient fluid-related fullness or bloating plausible, particularly during high-estradiol, relatively low-progesterone anovulatory cycles. However, direct prospective evidence linking measured perimenopausal hormone/fluid changes to validated bloating symptoms remains limited.

Clinical implications

• Mood changes merit consideration of sleep disruption, stress, psychiatric history, medications, and medical contributors.
• New, persistent, or progressive bloating/increasing abdominal girth—especially with early satiety, pelvic pressure, urinary or bowel change, nausea, fatigue, edema, or rapid weight gain—should not be automatically attributed to menopause.

Bottom line

• Fluctuating estrogen exposure during perimenopause has supported effects on neurotransmitter and fluid-regulatory physiology, making mood changes and bloating biologically credible; individual symptoms nevertheless require broader clinical assessment.